For medical device reimbursement in Japan, manufacturers must provide evidence of clinical efficacy, safety, cost-effectiveness, & alignment with healthcare standards. Data includes clinical trial results, real-world evidence, & comparisons to similar devices. Economic evaluations & documentation showing patient benefits are essential for approval by MHLW & Chuikyo under the NHI framework.
